Prevalence of glycemic control and use of diabetes technology lowest in Hispanic, non-Hispanic Black, Medicaid-insured.

High intake of the artificial sweetener sucralose may reduce the efficacy of ICIs in patients with cancer, data suggest.

Research links environmental exposures to CKD development and progression. Here’s what clinicians and patients need to know.

Stereotactic ablative body radiation therapy (SABR) is actively being explored for patients with renal cell carcinoma (RCC).

Findings seen across body mass index groups. (HealthDay News) — Metformin use is associated with lower risks for dementia and all-cause mortality across body mass index (BMI) groups in patients ...

Pembrolizumab plus lenvatinib is currently a standard of care for clear-cell renal cell carcinoma (RCC), so investigators assessed the combination for non-clear-cell RCC.

Research teams investigated the association between hemoglobin levels and cognitive impairment in patients with chronic kidney disease (CKD) or end-stage (ESKD).

DASH, DII are significantly associated with CKD risk, while only DII is associated with CKD severity progression.

The FDA has approved an expanded indication of the IV formulation of Avtozma to include the treatment of CRS in patients 2 years of age and older.

The poll also found a record 53% of adults consider moderate drinking — one or two drinks a day — is bad for their health. That’s up sharply from 28% in 2015, 39% in 2023, and 45% one year ago.

(HealthDay News) — In 2024, 26.5 percent of adults with diagnosed diabetes used glucagon-like peptide 1 receptor agonist (GLP-1 RA) injectables, according to an August data brief published by the ...

The Food and Drug Administration (FDA) has approved the first generic version of Venofer ® (iron sucrose) Injection.